Companies Launched

ACTSI resources offer funding for start-up research projects, better access to analytical tools, and education and training to clinical and translational investigators. ACTSI provides the infrastructure and programmatic foundation to rapidly identify and invest in promising technologies and enhance collaborative opportunities among translational investigators and industry partners. A goal of ACTSI is to catalyze development, validation, and commercialization of translational technologies. Through this mechanism, four companies used ACTSI support to launch and begin reaching patients.
Read More

Contact

Pamela Bhatti, PhD, MSCR

Upcoming Events

View All Events

Discovery News

Training

KL2 Scholar Studies Novel Hematopoietic Stem Cell Approach to Sickle Cell Disease Treatment

Elizabeth Stenger, MD, MSc, assistant professor, Department of Pediatrics, Emory University School of Medicine, received a K23 award for her work on improving haploidentical hematopoietic stem cell transplantation in sickle cell disease using...

Discovery

New Web Resource: Innovation & Translation Ecosystem

This new ACTSI webpage offers acceleration and incubation resources, entrepreneurship education, technology transfer offices, stories of success, and more.